Max Healthcare Institute Limited

Max Healthcare Institute Limited

Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding a show cause cum demand notice received by its wholly-owned subsidiary Alps Hospital Limited from the Office of the Pr. Additional Director General, Mumbai Zonal Unit, Directorate General of Goods & Services Tax Intelligence for alleged non-payment of GST on variable management fee.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has announced its Q1 FY27 earnings, with revenue and operating EBITDA growth of 16% and 15% year-on-year, respectively. The company has also made progress on its capacity expansion plans, including the operationalization of 50% of the 400-bed brownfield tower at Max Smart and the integration of Max Bhubaneswar into the network.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has informed the Exchange about a development in a pending litigation against its subsidiary Kalinga Hospital Ltd. The matter was heard by the National Company Law Tribunal on August 19, 2026, and was adjourned for further hearing on September 8, 2026.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has informed the Exchange about Investor Presentation for Motilal Oswal 22nd Annual Global Investor Conference on August 18, 2026.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, in compliance with SEBI Listing Regulations.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has informed the Exchange about the availability of the audio recording of its earnings call held on August 14, 2026, for the quarter ended June 30, 2026, on its website.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the upgrade of its ESG ratings by Crisil ESG Ratings & Analytics Limited.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has informed the Exchange about Resignation of Director/KMP/SMP

Max Healthcare Institute Limited

Max Healthcare Institute Limited has informed the Exchange about Change in Senior Management Personnel

Max Healthcare Institute Limited

Max Healthcare Institute Limited has announced its financial and operating results for the first quarter ended June 30, 2026, with network gross revenue of ₹ 2,982 Cr, reflecting a growth of 16% YoY. Network Operating EBITDA was ₹ 704 Cr, reflecting a growth of 15% YoY. The company has also completed the acquisition of a controlling stake in Kalinga Hospital Limited and Yerawada Properties Private Limited.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has announced its Q1 FY27 financial and operating results, with network gross revenue rising to ₹ 2,982 Cr, a growth of 16% YoY. Network Operating EBITDA stood at ₹ 704 Cr, a growth of 15% YoY. The company has also completed the acquisition of a controlling stake in Kalinga Hospital Limited and Yerawada Properties Private Limited.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has submitted its financial results for the quarter ended June 30, 2026, and announced several key developments, including the appointment of new senior management personnel, a capital expenditure of ₹425 Crore for the expansion of Max Super Speciality Hospital, Vaishali, and in-principle approval to explore setting up of medical colleges/medical institutions.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has informed the Exchange regarding the allotment of 3,048 equity shares under the Max Healthcare Institute Limited - Employee Stock Option Scheme 2022.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has granted 361,827 stock options to eligible employees under the Max Healthcare Institute Limited - Employee Stock Option Scheme 2022.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has informed the Exchange about the schedule of an investor conference to be held on August 18, 2026, at the Grand Hyatt in Mumbai, where the company's representatives will participate in the 22nd Annual One on one & Global Investor Conference.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has scheduled an earnings call for investors and analysts on August 14, 2026, to discuss Q1 FY27 results.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has informed the Exchange about disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the pendency of litigation(s)/dispute(s) or the outcome impacting the Company.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has held its 25th Annual General Meeting on July 30, 2026, through video conference, with 160 members in attendance, including representatives. The meeting was conducted in compliance with the Companies Act, 2013, and SEBI regulations.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has informed the Exchange about the transcript of its 25th Annual General Meeting held on July 30, 2026, through video conference.

Max Healthcare Institute Limited

Max Healthcare Institute Limited has held its 25th Annual General Meeting, where shareholders passed 8 resolutions, including the adoption of audited standalone and consolidated financial statements for the financial year 2025-26, declaration of a final dividend of ₹2 per equity share, and re-appointment of directors.